Prostate Cancer - Results from #26580

Quantitative RT-PCR analysis of PSA and prostate-specific membrane antigen mRNA to detect circulating tumor cells improves recurrence-free survival nomogram prediction after radical prostatectomy - Abstract February 2, 2012

Body mass index and incidence of localized and advanced prostate cancer--a dose-response meta-analysis of prospective studies - Abstract February 2, 2012

Diagnostic performance of malignant prostatic cells detection in blood for early detection of prostate cancer: Comparison to prostatic biopsy - Abstract February 2, 2012

Dynamic contrast-enhanced MR imaging findings of bone metastasis in patients with prostate cancer - Abstract February 2, 2012

Factors implicated in radiation therapy failure and radiosensitization of prostate cancer - Abstract February 2, 2012

Influence of PSA, PSA velocity and PSA doubling time on contrast-enhanced (18)F-choline PET/CT detection rate in patients with rising PSA after radical prostatectomy - Abstract February 2, 2012

Human prostate cancer ZIP1/zinc/citrate genetic/metabolic relationship in the TRAMP prostate cancer animal model - Abstract February 2, 2012

Prognostic determinants in prostate cancer - Abstract February 2, 2012

Effect of dietary polyunsaturated fatty acids on castration-resistant Pten-null prostate cancer - Abstract February 2, 2012

α-Mangostin, a xanthone from mangosteen fruit, promotes cell cycle arrest in prostate cancer and decreases xenograft tumor growth - Abstract February 2, 2012

Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness - Abstract February 2, 2012

Meta-analysis demonstrates no association between p53 codon 72 polymorphism and prostate cancer risk - Abstract February 2, 2012

Implications of treatment on body image and quality of life - Abstract February 1, 2012

Prospective randomized trial of barbed polyglyconate suture to facilitate vesico-urethral anastomosis during robot-assisted radical prostatectomy: Time reduction and cost benefit - Abstract February 1, 2012

The value of urinary prostate cancer gene 3 (PCA3) scores in predicting pathological features at radical prostatectomy - Abstract February 1, 2012

Optimal baseline prostate-specific antigen level to distinguish risk of prostate cancer in healthy men between 40 and 69 years of age - Abstract February 1, 2012

Treatment given near the end of life in castration-resistant prostate cancer - Abstract February 1, 2012

Lymph node staging with choline PET/CT in patients with prostate cancer: A review - Abstract February 1, 2012

Paraneoplastic neurological and hematological syndromes associated with prostate cancer - Abstract February 1, 2012

Evaluation of clinical benefits achievable by using different optimization algorithms during real-time prostate brachytherapy - Abstract February 1, 2012

Page 1330 of 1447